CNCR Summary

CNCR

The Loncar Cancer Immunotherapy ETF

ETF Information as of

ETF Summary

ETF Info
Primary Exchange NASDAQ
Ticker CNCR
Index Symbol LCINDX
Index Provider Loncar Investments, LLC
Index Calculator Indxx, LLC
CUSIP 26922A826
Net Assets
Shares Outstanding
Number of Holdings
Weighting Equal-Weighted
Rebalanced Semi-Annually
Reconstituted Semi-Annually
Fund Inception Date 10/13/15
Management Fee 0.79%
Gross Expense Ratio 0.79%
Nav
Net Asset Value
Daily Change
Market Price
Closing Price
Daily Change
Premium Discount
NAV
Mid-Point
Premium/Discount
Distributions
Ex-Date 12/29/2015
Record Date 12/31/2015
Payable Date 1/4/2016
Amount $0.10551286
Short-Term Capital Gains N/A

The fund's investment in securities that are less actively traded or over time experience decreased trading volume may affect adversely the fund's ability to make dividend distributions.

Download Investor Materials